Dave A. Chokshi

Learn More
G enomic research has the potential to improve global health by elucidating basic mechanisms of disease, susceptibility, and resistance, thereby guiding the development of preventive interventions [1]. Recently developed methods for exploring how human genetic variation affects resistance are likely to provide strategic clues about vaccine development for(More)
A ccording to the World Health Organization, about 10 million people—most of them in low-and middle-income countries—die needlessly every year because they do not have access to existing medicines and vaccines [1]. Countless others suffer from neglected tropical diseases, such as sleeping sickness, lymphatic fi lariasis, and blinding trachoma, for which(More)
BACKGROUND Pharmaceutical advertisements have been argued to provide revenue that medical journals require but they are intended to alter prescribing behaviour and they are known to include low quality information. We determined whether a difference exists in the current level of pharmaceutical advertising in print general medical journals, and we estimated(More)
BACKGROUND This article centers around a proposal outlining how research universities could leverage their intellectual property to help close the access gap for health innovations in poor countries. A recent deal between Emory University, Gilead Sciences, and Royalty Pharma is used as an example to illustrate how 'equitable access licensing' could be put(More)
  • 1